BPIQ Blog

Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...

Big PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...

BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...

Consistent with top 36 biopharma hedge funds • Each held 22-125 companies @ end Q1 ⇒ Stonepine (22 companies) ⇒ EcoR1 (58) ⇒ RA Capital...

But, which is the best? • Some anti-beta amyloids (ABs) made it ⇒ thru pos Ph3 ⇒ 1 full FDA approval But lots of ABs have died in...